Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03234556 · ClinicalTrials.gov registry record · NA
Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSA
A NA study of Health Status Unknown and Elevated PSA, sponsored by University of Southern California.
- Active
- Registry status
- NA
- Development phase
- 288
- Enrollment target
- 4
- Study locations
NCT03234556 is a NA study of Health Status Unknown and Elevated PSA that is active but no longer recruiting, run by University of Southern California. The registered enrollment target is 288 participants, below the 1,280-participant average among 6 other Health Status Unknown trials with a reported enrollment target (77% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT03234556, a NA study of Health Status Unknown and Elevated PSA, is active but no longer recruiting, sponsored by University of Southern California.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 288 participants
- Enrollment target
- 4
- Study locations
Study Summary
This randomized phase II trial studies how well systematic random biopsy or magnetic resonance imaging (MRI)-ultrasound image (US) fusion biopsy work in diagnosing prostate cancer in patients with elevated prostate specific antigen. Systematic random biopsy and MRI-US fusion biopsy may work better in improving the accuracy of prostate cancer detection.
Conditions Studied
Interventions
- OTHER Laboratory Biomarker Analysis
- PROCEDURE Biopsy of Prostate
- DIAGNOSTIC_TEST Magnetic Resonance Imaging
- DIAGNOSTIC_TEST MRI Ultrasound Fusion Guided Biopsy
Study Locations (4)
California
- USC / Norris Comprehensive Cancer Center - Los Angeles
Maryland
- University of Maryland - Baltimore
Michigan
- Henry Ford Hospital Vattikuti Urology Institute - Detroit
New York
- Memorial Sloan-Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2017-09-25 |
| Est. Completion | 2028-05-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03234556
The ClinicalTrials.gov registry entry for NCT03234556 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 288 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,280-participant average among 6 other Health Status Unknown trials with a reported enrollment target (77% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Health Status Unknown appearing as the primary indexed condition, and to 4 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT03234556 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Maryland, Michigan.
Frequently Asked Questions
What is clinical trial NCT03234556 about?
NCT03234556 is a clinical study titled "Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSA". This randomized phase II trial studies how well systematic random biopsy or magnetic resonance imaging (MRI)-ultrasound image (US) fusion biopsy work in diagnosing prostate cancer in patients with elevated prostate specific antigen. Systematic random biopsy and MRI-US fusion biopsy may work better i...
What is the current status of trial NCT03234556?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 288 participants. The study started on 2017-09-25. Estimated completion is 2028-05-23.
What conditions does trial NCT03234556 study?
This clinical trial studies the following conditions: Health Status Unknown, Elevated PSA.
What interventions are being tested in trial NCT03234556?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Biopsy of Prostate (PROCEDURE), Magnetic Resonance Imaging (DIAGNOSTIC_TEST), MRI Ultrasound Fusion Guided Biopsy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03234556?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03234556 being conducted?
This trial has 4 study locations across California, Maryland, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health Status Unknown
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Your Health Matters! (Tu Salud ¡Si Cuenta!): Promoting Healthy Lifestyles in Latino Families
ACTIVE NOT RECRUITING · NA
-
Patients Navigators in Facilitating Weight Management in Obese Participants
ACTIVE NOT RECRUITING · NA
-
Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
ACTIVE NOT RECRUITING · NA
-
Art Therapy for Caregivers of Young Patients Undergoing Bone Marrow Transplant for Cancer
COMPLETED · NA
-
Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma
COMPLETED · NA
-
Blood and Tissue Sample Collection for Future Colon Cancer Biomarker Studies in Patients Undergoing Colonoscopy
COMPLETED
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.